These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21212718)

  • 1. Challenging special interest groups: whistleblowers may help. Help them!
    Braillon A
    Psychother Psychosom; 2011; 80(2):116-7. PubMed ID: 21212718
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from the Mediator scandal.
    Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
    [No Abstract]   [Full Text] [Related]  

  • 3. Mediator: who's to blame?
    Braillon A
    Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
    [No Abstract]   [Full Text] [Related]  

  • 4. European drug regulator is being investigated by fraud agency.
    Kmietowicz Z
    BMJ; 2011 Nov; 343():d7283. PubMed ID: 22077089
    [No Abstract]   [Full Text] [Related]  

  • 5. Mediator: who's to blame?
    Waller P; Evans S
    Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
    [No Abstract]   [Full Text] [Related]  

  • 6. Weighing benefits and risks of drug to treat obesity.
    Sukkari SR
    CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
    [No Abstract]   [Full Text] [Related]  

  • 7. Benfluorex: how many deaths?
    Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
    [No Abstract]   [Full Text] [Related]  

  • 8. Mediator scandal rocks French medical community.
    Mullard A
    Lancet; 2011 Mar; 377(9769):890-2. PubMed ID: 21409784
    [No Abstract]   [Full Text] [Related]  

  • 9. [What were the indications for the Mediator in 1979?].
    Nau JY
    Rev Med Suisse; 2011 Feb; 7(281):374-5. PubMed ID: 21416722
    [No Abstract]   [Full Text] [Related]  

  • 10. Mediator: who's to blame?
    Vincent L; Guardiola B; Tsouderos Y; Canet E
    Lancet; 2011 Jun; 377(9782):2003. PubMed ID: 21665033
    [No Abstract]   [Full Text] [Related]  

  • 11. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventures in scientific discourse.
    Manson JE
    Epidemiology; 1997 May; 8(3):324-7. PubMed ID: 9115032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
    Ortensio A; Avagnina S; Costantino A
    Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug to treat obesity: editorial writer responds.
    Faich GA
    CMAJ; 1997 Apr; 156(7):978. PubMed ID: 9099162
    [No Abstract]   [Full Text] [Related]  

  • 15. European Medicines Agency withdrawal for sibutramine.
    Galhardo J; Davis N; Matthai S; Shield JP
    Arch Dis Child; 2010 Oct; 95(10):856. PubMed ID: 20573736
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical professionalism--focusing on the real issues.
    Rothman DJ
    N Engl J Med; 2000 Apr; 342(17):1284-6. PubMed ID: 10787328
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical virtue ethics: healthcare whistleblowing and portable digital technology.
    Bolsin S; Faunce T; Oakley J
    J Med Ethics; 2005 Oct; 31(10):612-8. PubMed ID: 16199607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. With new diet drug, challenge is weighing patient demand and potential benefit.
    Jones L
    Ann Intern Med; 1996 Aug; 125(4):I58. PubMed ID: 9446497
    [No Abstract]   [Full Text] [Related]  

  • 19. Mediator scandal engulfs French compensation body.
    Mullard A
    Lancet; 2013 May; 381(9880):1803. PubMed ID: 23717833
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflicts of interest--editorialists respond.
    Manson JE; Faich GA
    N Engl J Med; 1996 Oct; 335(14):1064-5. PubMed ID: 8801448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.